CHRISTUS Health anno
CHRISTUS Health announces new affiliation with Texas A&M
October 07, 2021 09:30 ET | Christus Health
Longview, TX, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Texas A&M and CHRISTUS Health today announced a new collaboration to help ensure that Northeast Texas will have access to world-class health...
Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University
August 24, 2021 10:44 ET | Sorrento Therapeutics, Inc.
MPro is a SARS-CoV-2 enzyme that catalyzes the formation of a number of essential proteins for the viral reproduction.MPro inhibitors block this catalytic process to potentially inhibit the viral...